Select a country Year from: Year to:  
 
 
 
 
 
 
 
 
 

HBeAg+ rate = %

Perinatal Prophylaxes Protocol


• Birth-dose is defined as first dose being administered ≤24 hours of birth. However, this definition is not universal but reported data on verified countries can be relied upon.


In the table below, vaccination rates in 2015 of reported data are shown (most recent figure shown)

Birth Dose
≥ 3 Dose
HBIG
Treated
Infants born to HBsAg+ Mothers
Infants born to HBsAg- Mothers
HVL/HBeAg+ Mothers


 

  • The Status Quo scenario describes the disease burden at the time of country meetings.
  • The WHO Target scenario describes the integrated healthcare strategy proposed by World Health Organization which includes: a) 90% reduce in new infections, b) 90% increase in diagnosis rate c) 80% treatment eligibility and d) 65% reduction in HCV mortality in 2030, compared to status quo in 2030 (1).
  • Actual treated patients in the 2015 were the number of treated patients between Jan-June of 2015. This value was multiplied by two to get an estimate for a full year.
  • References:

  • World Health Organization. Global Health Observatory Data Repository:Hepatitis B (HepB3). Accessed: 7/16/2016.
  • World Health Organization. Global Health Observatory Data Repository:Hepatitis B (HepB1). Accessed 7/16/2016.
  • World Health Organization. Global policy report on the prevention and control of viral hepatitis in WHO member states. 2013.
  • Polaris Observatory was developed by:  
    Made possible through funding from:
    The CDA Foundation  
    John Martin Foundation

    Copyright © polarisobservatory.com All rights reserved